Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose IVIG versus saline for carbamazepine-refractory trigeminal neuralgia
2007-004226-25Phase 4Terminated
- Sponsor
- UCL
- Start
- Oct 2007
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in trigeminal neuralgia (TN) comparing Gamunex with 0.9% saline placebo (2 arms). Primary endpoint: Patients remaining in trial at day 14 due to significant pain relief. Started Oct 2007; status: terminated.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on 2007-004226-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004226-25.